| Q41629363 | 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties |
| Q90254956 | A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability |
| Q39794430 | Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model |
| Q96132534 | Cationic/Anionic Polyelectrolyte (PLL/PGA) Coated Vesicular Phospholipid Gels (VPGs) Loaded with Cytarabine for Sustained Release and Anti-glioma Effects |
| Q33773101 | Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment |
| Q35556455 | Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer |
| Q86954174 | Core-shell nanoparticulate formulation of gemcitabine: lyophilization, stability studies, and in vivo evaluation |
| Q36791698 | EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer |
| Q39018240 | Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes |
| Q38058785 | Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives. |
| Q46033872 | Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts. |
| Q42915916 | Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation |
| Q34988879 | Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release |
| Q30405605 | Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells |
| Q37380284 | Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience. |
| Q89736510 | Novel Hyaluronic Acid Conjugates for Dual Nuclear Imaging and Therapy in CD44-Expressing Tumors in Mice In Vivo |
| Q33409922 | Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo |
| Q36218165 | Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model |